论文部分内容阅读
[目的]观察丹参川芎嗪联合尼可地尔片治疗不稳定型心绞痛临床疗效。[方法]不稳定型心绞痛60例,随机分为对照组和治疗组,每组30例。对照组在常规治疗的基础上口服尼可地尔片,治疗组加用丹参川芎嗪静脉滴注。[结果]心绞痛疗效,治疗组总有效率为83.3%,对照组为70.0%。心电图疗效:治疗组总有效率为53.3%,对照组为43.4%,两组相比(P<0.05)。[结论]丹参川芎嗪联合尼可地尔片治疗不稳定型心绞痛疗效显著、安全可靠。
[Objective] To observe the clinical effect of ligustrazine plus nikolaldil tablets in the treatment of unstable angina pectoris. [Methods] 60 patients with unstable angina were randomly divided into control group and treatment group, 30 cases in each group. In the control group, Nicorandil tablets were given orally on the basis of routine treatment. The treatment group was given intravenous infusion of Danshen ligustrazine. [Result] The curative effect of angina pectoris was 83.3% in the treatment group and 70.0% in the control group. Electrocardiogram Efficacy: The total effective rate was 53.3% in the treatment group and 43.4% in the control group, compared with the two groups (P <0.05). [Conclusion] Ligustrazine tetramethylpyrazine combined with nicorandil tablets in treatment of unstable angina pectoris has obvious effect and is safe and reliable.